Evidence map›Paper›PMID 35790340›Full record

ArticleImmunoHorizons2022

Transcriptional and Cytotoxic Responses of Human Intestinal Organoids to IFN Types I, II, and III.

David A Constant, Jacob A Van Winkle, Eden VanderHoek, Simone E Dekker, M Anthony Sofia, Emilie Regner, Nir Modiano, V Liana Tsikitis, Timothy J Nice

Open access · goldAbstract read
In one paragraph

Article in ImmunoHorizons, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Threonine phosphorylation of STAT1 safeguards gut epithelial integrity and restricts interferon-mediated cytotoxicity.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

David A ConstantDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR; nice@ohsu.edu d.a.constant@gmail.com.ORCID 0000-0001-9656-078X
Jacob A Van WinkleDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR.ORCID 0000-0002-4422-4175
Eden VanderHoekDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR.
Simone E DekkerDivision of Medicine, Oregon Health & Science University, Portland, OR.
M Anthony SofiaDivision of Gastroenterology and Hepatology, Oregon Health & Science University, Portland, OR; and.ORCID 0000-0003-1303-6611
Emilie RegnerDivision of Gastroenterology and Hepatology, Oregon Health & Science University, Portland, OR; and.
Nir ModianoDivision of Gastroenterology and Hepatology, Oregon Health & Science University, Portland, OR; and.
V Liana TsikitisDepartment of Surgery, Oregon Health & Science University, Portland, OR.ORCID 0000-0002-5216-2971
Timothy J NiceDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR; nice@ohsu.edu d.a.constant@gmail.com.ORCID 0000-0002-4471-7666
Oregon Health & Science University · US

Funding

Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)UL1TR002369 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Cynthia D Morris, Christopher G. Slatore · 2017 to 2026
$78.4M
INTERACTIONS AT THE MICROBE/HOST INTERFACET32AI007472 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI LANDFEAR, SCOTT M · 1995 to 2019
$6.7M
Innate immunity to enteric virus infection by IFN?-stimulated-gene expressionR01AI130055 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI Timothy J. Nice · 2017 to 2026
$4.2M
NCATS NIH HHS UL1 TR002369NIAID NIH HHS R01 AI130055NIAID NIH HHS T32 AI007472
6 · The paper itself

Abstract

The three types of IFN have roles in antimicrobial immunity and inflammation that must be properly balanced to maintain tissue homeostasis. For example, IFNs are elevated in the context of inflammatory bowel disease and may synergize with inflammatory cytokines such as TNF-α to promote tissue damage. Prior studies suggest that in mouse intestinal epithelial cells (IECs), type III IFNs are preferentially produced during viral infections and are less cytotoxic than type I IFN. In this study, we generated human IEC organoid lines from biopsies of ileum, ascending colon, and sigmoid colon of three healthy subjects to establish the baseline responses of normal human IECs to types I, II, and III IFN. We found that all IFN types elicited responses that were qualitatively consistent across intestinal biopsy sites. However, IFN types differed in magnitude of STAT1 phosphorylation and identity of genes in their downstream transcriptional programs. Specifically, there was a core transcriptional module shared by IFN types, but types I and II IFN stimulated unique transcriptional modules beyond this core gene signature. The transcriptional modules of type I and II IFN included proapoptotic genes, and expression of these genes correlated with potentiation of TNF-α cytotoxicity. These data define the response profiles of healthy human IEC organoids across IFN types, and they suggest that cytotoxic effects mediated by TNF-α in inflamed tissues may be amplified by a simultaneous high-magnitude IFN response.

Indexed as

OrganoidsTumor Necrosis Factor-alphaAnimalsCytokinesEpithelial CellsHumansIntestinesMiceCytokinesTumor Necrosis Factor-alpha

Identifiers

PMID35790340
PMCPMC10243893
OpenAlexW4283834588

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.